Literature DB >> 35367939

Alcohol use and alcohol use disorder differ in their genetic relationships with PTSD: A genomic structural equation modelling approach.

Kaitlin E Bountress1, Leslie A Brick2, Christina Sheerin3, Andrew Grotzinger4, Daniel Bustamante5, Sage E Hawn6, Nathan Gillespie3, Robert M Kirkpatrick3, Henry Kranzler7, Rajendra Morey8, Howard J Edenberg9, Adam X Maihofer10, Seth Disner11, Allison Ashley-Koch12, Roseann Peterson3, Adriana Lori13, Dan J Stein14, Nathan Kimbrel15, Caroline Nievergelt10, Ole A Andreassen16, Jurjen Luykx17, Arash Javanbakht18, Nagy A Youssef19, Ananda B Amstadter3.   

Abstract

PURPOSE: Posttraumatic Stress Disorder (PTSD) is associated with increased alcohol use and alcohol use disorder (AUD), which are all moderately heritable. Studies suggest the genetic association between PTSD and alcohol use differs from that of PTSD and AUD, but further analysis is needed. BASIC PROCEDURES: We used genomic Structural Equation Modeling (genomicSEM) to analyze summary statistics from large-scale genome-wide association studies (GWAS) of European Ancestry participants to investigate the genetic relationships between PTSD (both diagnosis and re-experiencing symptom severity) and a range of alcohol use and AUD phenotypes. MAIN
FINDINGS: When we differentiated genetic factors for alcohol use and AUD we observed improved model fit relative to models with all alcohol-related indicators loading onto a single factor. The genetic correlations (rG) of PTSD were quite discrepant for the alcohol use and AUD factors. This was true when modeled as a three-correlated-factor model (PTSD-AUD rG:.36, p < .001; PTSD-alcohol use rG: -0.17, p < .001) and as a Bifactor model, in which the common and unique portions of alcohol phenotypes were pulled out into an AUD-specific factor (rG with PTSD:.40, p < .001), AU-specific factor (rG with PTSD: -0.57, p < .001), and a common alcohol factor (rG with PTSD:.16, NS). PRINCIPAL
CONCLUSIONS: These results indicate the genetic architecture of alcohol use and AUD are differentially associated with PTSD. When the portions of variance unique to alcohol use and AUD are extracted, their genetic associations with PTSD vary substantially, suggesting different genetic architectures of alcohol phenotypes in people with PTSD.
Copyright © 2022 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alcohol use; Alcohol use disorder; Genetic architecture; Genetic correlation; Genomic structural equation modeling (genomicSEM); Posttraumatic stress disorder (PTSD)

Mesh:

Year:  2022        PMID: 35367939      PMCID: PMC9018560          DOI: 10.1016/j.drugalcdep.2022.109430

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.852


  47 in total

1.  Genetic and environmental influences on posttraumatic stress disorder, alcohol and drug dependence in twin pairs.

Authors:  H Xian; S I Chantarujikapong; J F Scherrer; S A Eisen; M J Lyons; J Goldberg; M Tsuang; W R True
Journal:  Drug Alcohol Depend       Date:  2000-12-22       Impact factor: 4.492

2.  Shared additive genetic variation for alcohol dependence among subjects of African and European ancestry.

Authors:  Leslie A Brick; Matthew C Keller; Valerie S Knopik; John E McGeary; Rohan H C Palmer
Journal:  Addict Biol       Date:  2017-11-27       Impact factor: 4.280

Review 3.  Synthesis of the psychometric properties of the PTSD checklist (PCL) military, civilian, and specific versions.

Authors:  Kendall C Wilkins; Ariel J Lang; Sonya B Norman
Journal:  Depress Anxiety       Date:  2011-06-16       Impact factor: 6.505

4.  The psychiatric GWAS consortium: big science comes to psychiatry.

Authors:  Patrick F Sullivan
Journal:  Neuron       Date:  2010-10-21       Impact factor: 17.173

Review 5.  Cannabis controversies: how genetics can inform the study of comorbidity.

Authors:  Arpana Agrawal; Michael T Lynskey
Journal:  Addiction       Date:  2014-01-19       Impact factor: 6.526

6.  Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II.

Authors:  J B Saunders; O G Aasland; T F Babor; J R de la Fuente; M Grant
Journal:  Addiction       Date:  1993-06       Impact factor: 6.526

7.  Shared molecular genetic risk of alcohol dependence and posttraumatic stress disorder (PTSD).

Authors:  Christina M Sheerin; Kaitlin E Bountress; Jacquelyn L Meyers; Stacey Subbie Saenz de Viteri; Hanyang Shen; Adam X Maihofer; Laramie E Duncan; Ananda B Amstadter
Journal:  Psychol Addict Behav       Date:  2020-03-19

8.  Item-Level Genome-Wide Association Study of the Alcohol Use Disorders Identification Test in Three Population-Based Cohorts.

Authors:  Travis T Mallard; Jeanne E Savage; Emma C Johnson; Yuye Huang; Alexis C Edwards; Jouke J Hottenga; Andrew D Grotzinger; Daniel E Gustavson; Mariela V Jennings; Andrey Anokhin; Danielle M Dick; Howard J Edenberg; John R Kramer; Dongbing Lai; Jacquelyn L Meyers; Ashwini K Pandey; Kathryn Paige Harden; Michel G Nivard; Eco J C de Geus; Dorret I Boomsma; Arpana Agrawal; Lea K Davis; Toni-Kim Clarke; Abraham A Palmer; Sandra Sanchez-Roige
Journal:  Am J Psychiatry       Date:  2021-05-14       Impact factor: 19.242

9.  Genome-Wide Association Study Meta-Analysis of the Alcohol Use Disorders Identification Test (AUDIT) in Two Population-Based Cohorts.

Authors:  Sandra Sanchez-Roige; Abraham A Palmer; Pierre Fontanillas; Sarah L Elson; Mark J Adams; David M Howard; Howard J Edenberg; Gail Davies; Richard C Crist; Ian J Deary; Andrew M McIntosh; Toni-Kim Clarke
Journal:  Am J Psychiatry       Date:  2018-10-19       Impact factor: 18.112

10.  Largest GWAS of PTSD (N=20 070) yields genetic overlap with schizophrenia and sex differences in heritability.

Authors:  L E Duncan; A Ratanatharathorn; A E Aiello; L M Almli; A B Amstadter; A E Ashley-Koch; D G Baker; J C Beckham; L J Bierut; J Bisson; B Bradley; C-Y Chen; S Dalvie; L A Farrer; S Galea; M E Garrett; J E Gelernter; G Guffanti; M A Hauser; E O Johnson; R C Kessler; N A Kimbrel; A King; N Koen; H R Kranzler; M W Logue; A X Maihofer; A R Martin; M W Miller; R A Morey; N R Nugent; J P Rice; S Ripke; A L Roberts; N L Saccone; J W Smoller; D J Stein; M B Stein; J A Sumner; M Uddin; R J Ursano; D E Wildman; R Yehuda; H Zhao; M J Daly; I Liberzon; K J Ressler; C M Nievergelt; K C Koenen
Journal:  Mol Psychiatry       Date:  2017-04-25       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.